Merck seeks first U.S. authorization for COVID-19 pill
Merck & Co Inc said on Monday it has applied for U.S. emergency use authorization for its drug to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease.Read in Reuters: https://apple.news/AjYOHrQZASVyVMzQqVzxzAQ